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Background
Few laboratories in resource-constrained countries can
afford to perform laboratory-monitoring tests required for
the implementation of HIV therapy. In this case control
study, we have investigated the relevance of absolute lym-
phocyte count as a surrogate marker for CD4 lymphocyte
count as a criterion for initiating HAART in HIV-infected
Nigerians.
Methods
A total of 100 consecutive recruited HIV-infected, previ-
ously antiretroviral naive persons and 30 HIV-negative
individuals blood samples were run for absolute lym-
phocyte and CD4 lymphocyte counts and results were
compared by a model of linear regression analysis.
Results
An overall modest correlation was observed between
absolute lymphocyte count and CD4 lymphocyte (r =
0.51) and at CD4 lymphocyte threshold relevant for clin-
ical management of HIV-infected; <200, 200-350 and
>350 cells/μL (r = 0.41, 0.30 and 0.21) respectively. Mean
absolute lymphocyte count of 1.60 +/- 0.77 × 10(9)/μL,
1.88 +/- 1.11 × 10(9)/μL and 2.04 +/- 0.54 × 10(9)/μL was
equivalent respectively to CD4 of <200, 200-350 and
>350 cells/μL.
Conclusion
This study indicates a modest correlation between abso-
lute and CD4 lymphocyte counts of HIV-infected Nigeri-
ans and at CD4 lymphocyte count threshold significant
for clinical management of HIV-infected. Absolute lym-
phocyte count can become a minimal inexpensive alterna-
tive to CD4 lymphocyte count in conjunction with WHO
staging and clinical status of patient in determining the
optimal time to initiate therapy particularly in resource
limited settings where other expensive methods of CD4
enumeration are unavailable.
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